Portal de Periódicos da CAPES

Usefulness of bronchoalveolar lavage in suspect COVID-19 repeatedly negative swab test and interstitial lung disease

2020; Elsevier BV; Volume: 23; Linguagem: Inglês

10.1016/j.jgar.2020.07.030

2213-7173

Jacopo Vannucci, Franco Ruberto, Daniele Diso, Gioacchino Galardo, Claudio Maria Mastroianni, Giammarco Raponi, Massimiliano Bassi, Giancarlo Ceccarelli, Massimo Mancone, Guido Antonelli, Federico Venuta, Francesco Pugliese, Alida Albante, Francesco Alessandri, Davide Amore, Marco Anile, Maria Gloria Antognoli, Fabio Araimo Morselli, Daniela Auricchio, Martina Bianco, Federico Bilotta, Lucia Ilaria Birtolo, Matteo Brisciani, Katia Bruno, M. Bufi, Sara Cagnetti, Elena Calzecchi, Alessandro Cappannoli, Carolina Carillo, Romina Casaretti, Carlo Catalano, Paola Celli, Stella Consolo, Croce Claudia, Beatrice Crocitti, Enrica Cuscianna, Federica D’Agostino, Tiziano De Giacomo, Daniela De Lauri, Francesco De Lazzaro, Maurizio Del Monte, Gabriella d’Ettorre, Valerio Di Bella, Francesco Fedele, Massimo Gentile, Giovanni Giordano, Stefano Ianni, Carmela Imperiale, Fabio Infusino, Cinzia Loiacono, Viviana Maestrini, Eugenia Magnanimi, Federica Maldarelli, Sara Mantovani, S. Martelli, Paolo Messercola, Teresa Messina, Emilia Mottola, Valeria Pati, Pattelli Elisa, Pecorari Filippo, Ylenia Pecoraro, Serena Maria Perrella, Piazzolla Mario, Valeria Pietropaolo, Camilla Poggi, Portieri Monica, Ratini Fabiola, Claudia Ricci, Paolo Ricci, Mario Rumori, Gianluca Russo, Pietro Santopietro, Guglielmo Tellan, Luca Titi, Tordiglione Paolo, Antonella Tosi, S. Tosti, Trigilia Fausto, Ombretta Turriziani, Paola Vaccaro, Noemi Verduci, Gabriella Vivino,

Respiratory viral infections research

The diagnosis of coronavirus disease 2019 (COVID-19) relies on nasopharyngeal swab, which shows a 20–30% risk of false negativity [1]. Bronchoalveolar lavage (BAL) is reported to be useful in patients with pulmonary interstitial infiltrates on high-resolution computed tomography (HRCT). We investigated the usefulness of BAL in symptomatic patients with positive HRCT and a repeatedly negative swab test (‘grey zone’).